18 results
10-Q
2024 Q1
TCBP
TC BioPharm (Holdings) plc
15 May 24
Quarterly report
4:06pm
across multiple programs and, as such, are not separately classified. We use internal resources primarily to oversee research and development as well
10-K/A
2023 FY
TCBP
TC BioPharm (Holdings) plc
29 Apr 24
Annual report (amended)
5:23pm
10A-3 under the Exchange Act. Our audit committee meets regularly each year and oversee and review our internal controls, accounting policies
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
and, as such, are not separately classified. We use internal resources primarily to oversee research and development as well as for managing our preclinical development
6-K
EX-99.2
TCBP
TC BioPharm (Holdings) plc
2 Nov 23
Current report (foreign)
12:57pm
to oversee research and development as well as for managing our preclinical development, process development, manufacturing and clinical development
6-K
EX-99.2
gzcq82gafxezen2
12 Dec 22
Current report (foreign)
9:00am
20-F
8xtblzc 67c
13 May 22
Annual report (foreign)
3:56pm
424B4
1gxna4q
2 Mar 22
Prospectus supplement with pricing info
12:03pm
424B4
xbici
14 Feb 22
Prospectus supplement with pricing info
5:10pm
424B4
ie17 fm5w
14 Feb 22
Prospectus supplement with pricing info
12:00am
F-1/A
94trxka
9 Feb 22
Registration statement (foreign) (amended)
5:01pm
F-1/A
6vgcalx51qme 0dl
31 Jan 22
Registration statement (foreign) (amended)
4:51pm
F-1/A
9dhg5z8ri anuy19106
14 Jan 22
Registration statement (foreign) (amended)
5:29pm
F-1/A
wrhel fcs6o8fh
23 Dec 21
Registration statement (foreign) (amended)
5:14pm
F-1/A
wxy39qd 57iq
27 Oct 21
Registration statement (foreign) (amended)
1:47pm
F-1
k3tv7 4ec8xo
26 Oct 21
Registration statement (foreign)
12:00am
DRS/A
39qq0e xmdoru
17 Sep 21
Draft registration statement (amended)
12:00am
DRS
qagqd
26 Jul 21
Draft registration statement
12:00am
- Prev
- 1
- Next